THERAPY OF TOMORROW
We'd love to hear from you
Invention regarding our peptide drug discovery has patented on Nov 22.
Title of the Invention: mRNA display method using head-to-head bridge.
Patentee: Saitama Univ., Mescue-Janusys Inc.
Uploading the Presentation Material presented by Dr. Koichiro Kitamura, President & CEO that introduced a novel therapeutic approach for the treatment of Amyotrophic Lateral Sclerosis (ALS) at the「Healthcare Venture KNOT 2019」which was held in Tokyo, Japan on October 26, 2019.
Dr. Koichiro Kitamura, President & CEO has been invited to speak at the「Healthcare Venture KNOT 2019」which will be held in Tokyo, Japan on October 26, 2019.
Our Senior Business Development Manager, Waleed Osman will be a keynote speaker in the "2nd International Conference on Cell and Stem Cell Research" which will be held at Osaka, Japan on October 24, 2019.
Our website has been renewed with a new address and refreshed design following the new corporate identity.
MeSCue-Janusys is pleased to announce its participation in PharmaLab JAPAN EXPO conference and exhibition event held at Tokyo Big Sight, Japan, 3 - 5 July 2019. Booth number A-V10.